Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
27 Sep 2022
// YICAIGLOBAL
https://www.yicaiglobal.com/news/frontier-biotech-gains-after-china-permits-inhaled-covid-19-drug-to-start-trials
08 Aug 2022
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/frontier-covid-drug-trial/
08 Aug 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/frontier-biotechnologies-announces-positive-phase-1-results-of-its-first-coronavirus-main-protease-mpro-small-molecule-inhibitor-laying-foundation-for-the-treatment-of-acute-and-long-covid-301601537.html
https://www.pharmacompass.com/pdf/news/affiris-and-frontier-biotechnologies-announce-license-agreement-for-affitopeat04-an-active-immunotherapy-targeting-pcsk9-to-treat-hypercholesterolemia-in-greater-china-1642055496.pdf
27 Oct 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/frontier-biotechnologies-long-acting-injectable-aikeningr-in-a-two-drug-regimen-proves-safe-and-effective-for-critically-ill-hospitalized-aids-patients-301409816.html
ABOUT THIS PAGE